<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=668513913540741&amp;ev=PageView&amp;noscript=1">

Clearway Pain Solutions Institute Among First Pain Clinics in the Country to Use Non-Opioid Treatment for Patients with Chronic Pain

Spectra WaveWriterTM Spinal Cord Stimulator System allows patients to combine therapeutic options and customize treatment

Pensacola, FL, August 22, 2018 – Clearway Pain Solutions Institute is among the first pain clinics in the country to offer the Spectra WaveWriterTM Spinal Cord Stimulator System to patients with chronic pain. It’s the first and only system approved by the FDA to simultaneously provide paresthesia-based and sub-perception stimulation. Paresthesia-based therapy provides pain relief with a light tingling sensation while sub-perception therapy works without that sensation.

 

Spinal cord stimulation (SCS) is an FDA approved non-opioid treatment option for people with chronic pain in the legs and back. The device sends low electrical pulses to the spinal cord that interrupt pain signals. Two thin wires, called leads, are implanted in the spine and powered by a rechargeable battery which is implanted in the chest.

 

With the Spectra WaveWriter System, patients can combine both of these therapies to target one specific area of pain or use each therapy as needed to best manage multiple areas of pain. Patients provide real-time feedback using the system's remote control. The Spectra WaveWriter System was developed with more than a decade of clinical research focused on optimizing sub-perception stimulation and delivering multiple therapies intended for more effective, long-term pain relief.

 

“Everyone experiences pain differently and patients can sometimes become less responsive to therapy as their pain changes over time,” said David Fairleigh, M.D., co-founder of Clearway Pain Solutions Institute. “The Spectra WaveWriter System is breakthrough technology that offers patients flexibility to meet their individual needs for lasting relief. Treatment options like this are important as we face the challenge of providing patients relief from pain without relying solely on opioids.”

 

More than 100 million Americans suffer from chronic pain and it is the number one cause of disability in adults in the U.S.1,2 SCS was introduced more than 40 years ago. Unlike most surgical procedures, it is reversible. Patients undergo a trial period allowing them to evaluate it before deciding to receive a permanent implant. To learn more, please visit www.clearwaypain.com or ControlYourPain.com.

 

About Clearway Pain Solutions Institute

 

Clearway Pain Solutions Institute is a leading pain management medical practice focused on relieving pain, restoring function and renewing quality of life for their patients. Clearway provides a compassionate, patient-centered, comprehensive system of integrated care that includes interventional treatments, medication management, chiropractic services, physical therapy, massage therapy and regenerative medicine, along with lab testing, durable medical equipment and pharmacy services. Founded in 2013 as Gulf Coast Pain Institute by three leading interventional pain management experts -- Jeff Buchalter, M.D., David Fairleigh, M.D., and Mark Larkins, M.D. – Clearway today has teams of multi-specialty pain management physicians, chiropractors, physical therapists, advanced practitioners and a dedicated support staff. Clearway serves a dozen communities in the Gulf Coast region of Florida, and is expanding into other regions of the U.S. For more information, please visit clearwaypain.com.

 

https://www.cdc.gov/drugoverdose/epidemic/index.html Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education and research. Washington, DC: National Academies Press, 2011.

 

CONTACT:

Jessica Sorsby, Practice Administrator

Clearway Pain Solutions Institute

439-5432

jsorsby@clearwaypain.com